{
  "claim_id": "claim_000",
  "claim": "Flublok ensures identical antigenic match with WHO- and FDA-selected flu strains.",
  "document": "Grohskopf_et_al.__2023_",
  "verified_evidence": [
    {
      "id": 2,
      "quote": "For the 2022-23 season, U.S.-licensed influenza vaccines will contain HA derived from an influenza A/Victoria/2570/2019 (H1N1) pdm09 like virus (for egg based vaccines) or an influenza A/Wisconsin/588/2019 (H1N1) pdm09 like virus (for cell culture based and recombinant vaccines); an influenza A/Darwin/9/2021 (H3N2)-like virus (for egg based vaccines) or an influenza A/Darwin/6/2021 (H3N2)-like virus (for cell culture based or recombinant vaccines); an influenza B/Austria/1359417/2021 (Victoria lineage like virus; and an influenza B/Phuket/3073/2013 (Yamagata lineage like virus.",
      "supports_claim": true,
      "explanation": "The quote appears on page 8 of the document, nearly verbatim: 'For the 2022-23 season, U.S.-licensed influenza vaccines will contain hemagglutinin (HA) derived from an influenza A/Victoria/2570/2019 (H1N1) pdm 09 like virus (for egg based vaccines) or an influenza A/Wisconsin/588/2019 (H1N1) pdm 09 like virus (for cell culture based and recombinant vaccines); an influenza A/Darwin/9/2021 (H3N2)-like virus (for egg based vaccines) or an influenza A/Darwin/6/2021 (H3N2)-like virus (for cell culture based or recombinant vaccines); an influenza B/Austria/1359417/2021 (Victoria lineage like virus; and an influenza B/Phuket/3073/2013 (Yamagata lineage like virus.' The factual content, strain names, and distinctions between egg-based, cell culture-based, and recombinant vaccines are all preserved.. The quote explicitly states that for the 2022-23 season, recombinant vaccines (which includes Flublok) will contain HA derived from the same WHO- and FDA-selected strains as other vaccine types. It lists the specific strains and notes that recombinant vaccines use the same antigenic targets as cell culture-based vaccines, which are selected to match the WHO and FDA recommendations. This directly supports the claim that Flublok ensures identical antigenic match with WHO- and FDA-selected flu strains.",
      "presence_explanation": "The quote appears on page 8 of the document, nearly verbatim: 'For the 2022-23 season, U.S.-licensed influenza vaccines will contain hemagglutinin (HA) derived from an influenza A/Victoria/2570/2019 (H1N1) pdm 09 like virus (for egg based vaccines) or an influenza A/Wisconsin/588/2019 (H1N1) pdm 09 like virus (for cell culture based and recombinant vaccines); an influenza A/Darwin/9/2021 (H3N2)-like virus (for egg based vaccines) or an influenza A/Darwin/6/2021 (H3N2)-like virus (for cell culture based or recombinant vaccines); an influenza B/Austria/1359417/2021 (Victoria lineage like virus; and an influenza B/Phuket/3073/2013 (Yamagata lineage like virus.' The factual content, strain names, and distinctions between egg-based, cell culture-based, and recombinant vaccines are all preserved.",
      "support_explanation": "The quote explicitly states that for the 2022-23 season, recombinant vaccines (which includes Flublok) will contain HA derived from the same WHO- and FDA-selected strains as other vaccine types. It lists the specific strains and notes that recombinant vaccines use the same antigenic targets as cell culture-based vaccines, which are selected to match the WHO and FDA recommendations. This directly supports the claim that Flublok ensures identical antigenic match with WHO- and FDA-selected flu strains.",
      "original_relevance": "This quote specifies the exact strains selected for the 2022-23 season and notes that recombinant vaccines (such as Flublok) use HA derived from the same WHO- and FDA-selected strains as other vaccine types, confirming the antigenic match."
    },
    {
      "id": "comp_2",
      "quote": "For the 2022-23 season, U.S. cell culture based inactivated (ccIIV4) and recombinant (RIV4) influenza vaccines will contain HA derived from \u2022 an influenza A/Wisconsin/588/2019 (H1N1) pdm09 like virus, \u2022 an influenza A/Darwin/6/2021 (H3N2)-like virus, \u2022 an influenza B/Austria/1359417/2021 (Victoria lineage) like virus, and \u2022 an influenza B/Phuket/3073/2013 (Yamagata lineage like virus.",
      "supports_claim": true,
      "explanation": "The quote appears on page 19 of the document: 'For the 2022-23 season, U.S. cell culture based inactivated (ccIIV4) and recombinant (RIV4) influenza vaccines will contain HA derived from \u2022 an influenza A/Wisconsin/588/2019 (H1N1) pdm09 like virus, \u2022 an influenza A/Darwin/6/2021 (H3N2)-like virus, \u2022 an influenza B/Austria/1359417/2021 (Victoria lineage) like virus, and \u2022 an influenza B/Phuket/3073/2013 (Yamagata lineage like virus.' This matches the quote to verify, with only minor formatting differences (e.g., bullet points and line breaks), but all factual content is preserved.. The quote explicitly states that for the 2022-23 season, recombinant influenza vaccines (RIV4, which includes Flublok) will contain HA derived from the specific strains listed. This matches the WHO- and FDA-selected strains for that season, as described elsewhere in the document. Therefore, the quote directly supports the claim that Flublok ensures identical antigenic match with WHO- and FDA-selected flu strains.",
      "presence_explanation": "The quote appears on page 19 of the document: 'For the 2022-23 season, U.S. cell culture based inactivated (ccIIV4) and recombinant (RIV4) influenza vaccines will contain HA derived from \u2022 an influenza A/Wisconsin/588/2019 (H1N1) pdm09 like virus, \u2022 an influenza A/Darwin/6/2021 (H3N2)-like virus, \u2022 an influenza B/Austria/1359417/2021 (Victoria lineage) like virus, and \u2022 an influenza B/Phuket/3073/2013 (Yamagata lineage like virus.' This matches the quote to verify, with only minor formatting differences (e.g., bullet points and line breaks), but all factual content is preserved.",
      "support_explanation": "The quote explicitly states that for the 2022-23 season, recombinant influenza vaccines (RIV4, which includes Flublok) will contain HA derived from the specific strains listed. This matches the WHO- and FDA-selected strains for that season, as described elsewhere in the document. Therefore, the quote directly supports the claim that Flublok ensures identical antigenic match with WHO- and FDA-selected flu strains.",
      "original_relevance": "This quote directly lists the specific strains from which the HA in Flublok (RIV4) is derived, showing that it matches the WHO- and FDA-selected strains for the 2022-23 season."
    }
  ],
  "verification_stats": {
    "total_verified": 2
  },
  "image_evidence": []
}